The canada contrast media market size is expected to reach USD 375.31 million by 2034, according to a new study by Polaris Market Research. The report “Canada Contrast Media Market Size, Share, & Industry Analysis Report: By Modality, By Product, By Application, By Route of Administration, By End Use (Hospital, Private Clinics, and Others) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Contrast media are substances used in medical imaging to enhance the visibility of internal structures such as blood vessels, organs, or tissues on scans such as X-rays, CTs, and MRIs.
Canada’s universal healthcare system ensures that all residents have access to medically necessary services, including diagnostic imaging. This broad access allows more people to undergo MRI and CT scans without worrying about high out-of-pocket costs. Since these scans often require contrast media to be effective, the public healthcare system helps maintain a strong demand for these products. The system also supports equal access across regions, ensuring that both large hospitals and smaller community clinics use contrast agents, contributing to the growth of the Canada contrast media market.
Canada is home to several leading research institutions and universities that actively collaborate with the medical imaging and pharmaceutical industries. These partnerships lead to innovations in contrast agent technology, such as safer formulations or agents tailored for specific imaging needs. Canadian companies and academic centers are further involved in clinical trials and product development, helping bring new solutions to the market. These technological advancements contribute to market growth by encouraging the use of newer products as they improve and become more widely adopted, thereby driving market growth.
Canada Contrast Media Market Report Highlights
In 2024, the iodinated segment dominated the Canada contrast media market due to its widespread use in CT scans, which are among the most commonly performed diagnostic imaging procedures in Canada.
The ultrasound segment is expected to witness the fastest growth during the forecast period, driven by the increasing use of contrast-enhanced ultrasound (CEUS) for real-time imaging of organs.
A few global key market players are Bayer AG, GE HealthCare, Guerbet, Lantheus, Bracco, Voyageur Pharmaceuticals Ltd, Grupo Juste, Franz Köhler Chemie GmbH, and MEDTRON AG.
Polaris Market Research has segmented the Canada contrast media market report on the basis of modality, product, application, route of administration, and end use:
By Modality (Revenue USD Million, 2020–2034)
Ultrasound
Magnetic Resonance Imaging
X-ray/Computed Tomography
By Product (Revenue USD Million, 2020–2034)
Microbubble
Gadolinium-Based
Iodinated
Iodixanol
Iohexol
Iopamidol
Others
Barium-Based
By Application (Revenue USD Million, 2020–2034)
Cardiovascular Disorders
Neurological Disorders
Gastrointestinal Disorders
Cancer
Nephrological Disorders
Musculoskeletal Disorders
Others
By Route of Administration (Revenue USD Million, 2020–2034)
Intravenous
Oral Route
Rectal Route
By End Use (Revenue USD Million, 2020–2034)
Hospitals
Private Clinics
Others
- 1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
- 2. Executive Summary
- 2.1. Market Highlights
- 3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
- 4. Canada Contrast Media Market Insights
- 4.1. Canada Contrast Media Market – Market Snapshot
- 4.2. Canada Contrast Media Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Rising Elderly Population
- 4.2.1.2. Rising Cases of Chronic Disease
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Initial Investment
- 4.3. Porter’s Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Canada Contrast Media Market Trends
- 4.6. Value Chain Analysis
- 5. Canada Contrast Media Market, by Modality
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Canada Contrast Media Market, by Modality, 2020-2034 (USD million)
- 5.3. Ultrasound
- 5.3.1. Canada Contrast Media Market, by Ultrasound, 2020–2034 (USD million)
- 5.4. Magnetic Resonance Imaging
- 5.4.1. Canada Contrast Media Market, by Magnetic Resonance Imaging, 2020–2034 (USD million)
- 5.5. X-ray/Computed Tomography
- 5.5.1. Canada Contrast Media Market, by X-ray/Computed Tomography, 2020–2034 (USD million)
- 6. Canada Contrast Media Market, by Product
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Canada Contrast Media Market, by Product, 2020-2034 (USD million)
- 6.3. Microbubble
- 6.3.1. Canada Contrast Media Market, by Microbubble, 2020–2034 (USD million)
- 6.4. Gadolinium-Based
- 6.4.1. Canada Contrast Media Market, by Gadolinium-Based, 2020–2034 (USD million)
- 6.5. Iodinated
- 6.5.1. Canada Contrast Media Market, by Iodinated, 2020–2034 (USD million)
- 6.5.2. Iodixanol
- 6.5.2.1. Canada Contrast Media Market, by Iodixanol, 2020–2034 (USD million)
- 6.5.3. Iohexol
- 6.5.3.1. Canada Contrast Media Market, by Iohexol, 2020–2034 (USD million)
- 6.5.4. Iopamidol
- 6.5.4.1. Canada Contrast Media Market, by Iopamidol, 2020–2034 (USD million)
- 6.5.5. Others
- 6.5.5.1. Canada Contrast Media Market, by Others, 2020–2034 (USD million)
- 6.6. Barium-Based
- 6.6.1. Canada Contrast Media Market, by Barium-Based, 2020–2034 (USD million)
- 7. Canada Contrast Media Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Canada Contrast Media Market, by Medical Biotechnology, 2020-2034 (USD million)
- 7.3. Cardiovascular Disorders
- 7.3.1. Canada Contrast Media Market, by Cardiovascular Disorders, 2020–2034 (USD million)
- 7.4. Neurological Disorders
- 7.4.1. Canada Contrast Media Market, by Neurological Disorders, 2020–2034 (USD million)
- 7.5. Gastrointestinal Disorders
- 7.5.1. Canada Contrast Media Market, by Gastrointestinal Disorders, 2020–2034 (USD million)
- 7.6. Cancer
- 7.6.1. Canada Contrast Media Market, by Cancer, 2020–2034 (USD million)
- 7.7. Nephrological Disorders
- 7.7.1. Canada Contrast Media Market, by Nephrological Disorders, 2020–2034 (USD million)
- 7.8. Musculoskeletal Disorders
- 7.8.1. Canada Contrast Media Market, by Musculoskeletal Disorders, 2020–2034 (USD million)
- 7.9. Others
- 7.9.1. Canada Contrast Media Market, by Others, 2020–2034 (USD million)
- 8. Canada Contrast Media Market, by Route of Administration
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Canada Contrast Media Market, by Route of Administration, 2020-2034 (USD million)
- 8.3. Intravenous
- 8.3.1. Canada Contrast Media Market, by Intravenous, 2020–2034 (USD million)
- 8.4. Oral Route
- 8.4.1. Canada Contrast Media Market, by Oral Route, 2020–2034 (USD million)
- 8.5. Rectal Route
- 8.5.1. Canada Contrast Media Market, by Rectal Route, 2020–2034 (USD million)
- 9. Canada Contrast Media Market, by End Use
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Canada Contrast Media Market, by Route of Administration, 2020-2034 (USD million)
- 9.3. Hospitals
- 9.3.1. Canada Contrast Media Market, by Hospitals, 2020–2034 (USD million)
- 9.4. Private Clinics
- 9.4.1. Canada Contrast Media Market, by Private Clinics, 2020–2034 (USD million)
- 9.5. Others
- 9.5.1. Canada Contrast Media Market, by Private Clinics, 2020–2034 (USD million)
- 10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
- 11. Company Profiles
- 11.1. Bayer AG
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Bracco
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Dr. Franz Köhler Chemie GmbH
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. GE HealthCare
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Grupo Juste
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Guerbet
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Lantheus
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. MEDTRON AG
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Voyageur Pharmaceuticals Ltd
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook